Long-term metastatic melanoma survival dramatically improves on immunotherapy
www.eurekalert.org
Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Center investigators and their colleagues.
This is an automated archive made by the Lemmit Bot.

The original was posted on /r/science by /u/FunnyGamer97 on 2024-09-15 16:50:40+00:00.

Original Title: Long-term metastatic melanoma survival dramatically improves on immunotherapy: Study finds half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more